. >> ariad pharmaceutica came under pressure after one of its treatm caugh the attention of former presidentialdidats tweeted, quote, drug corporat, greed is unbeliev. ariad has raised the price of a leukem drug to almost $199,000 a year, end the drug-maker had hyped the pr cancer medication six times since 2015. shares plunged nearly 15% to 11.14. >>> beverage giant, pepsico may be eyeing cavi it ta. pepsico, which already owns a minority stake is nearing a deal to take over the company. a potential deal, which is not guarante, ce finalized this month. pepsico shares rose nearly 1% to 106.83. > and hershey says its will retire from his role at the chocolate c next summer. is expected to stay on as nonexecu chairman. hershey shares up 78 cents to $96.43. >>> as earnings seas up, a lot of attention will be paid to the industrial sector. the group is watched closely because it sells products across a lot of different industries in a lot of countries. d it is often vutd as a proxy for the global economy. a handful of large global industri rep earnings in the coming weeks and have already in some c

following our lead on compounds we've targeted, and we've had follow-on funding and we will fund a pharmaceutica do initial research and derisk it for them and then what happens they make breakthroughs and it's open. >> you're starting to learn a more from people like you who have parkinson's with wearable technology and can really teach us so much about what's going on. >> the technology is amazing. the watches and the devices that people can wear that track the disease 24/7. so you get a much more complete picture of the life of a person about parkinson's, everyone has their own version so what we're doing is through research is finding ways to attack whatever issue you may have, and right now we have a one size fits all drug therapy and we need to find other drugs that target specific versions of the disease that affect different people differently. >> and all of you at home can help fund that research by entering the drawing for these pair of nike mags it. website. the foundation website. also on our "gma" website as well. the drawing ends october 11th. 100% goes to the michael j. fox founda

i think that's a small possibility, but we could see effects on pharmaceutica stocks. to the extent that clinton is in favor of more regulation of drugs, banks and oil companies, that could be an issue. look at big pharma. abbott, merck, johns johnson & johnson, all down 2% to 4%. banks, clinton in favor of more regulation of banks. see banks at 52-week highs. even yesterday, all of them down today. finally, energy stocks also in favor of more regulation of that sector and you see that. i'm not saying this is the primary factor that we're down, but this is becoming an issue. i think the election is clearly starting to influence some sentiment on wall street. back to you. >> bob, thank you very much. verizon communications ceo lowell mcadam weighing in on the samsung phone crisis on cnbc monday. take a listen to what he told our julia boorstin. >> this is by far the biggest concern i've seen in cell phones during my tenure. i do expect samsung will get back on their feet. they have got a lot of high quality engineers. they got a good customer focus. this is clearly a bl